Overall Status

Completed (8)

Recruiting (6)

Unknown status (6)

Not yet recruiting (4)

Active, not recruiting (3)

Terminated (3)

Phase

n/a (5)

phase 2 (4)

phase 1 (2)

phase 3 (1)

phase 4 (1)

Study Documents

Individual Participant Data Set (1)

Study Protocol (1)

Study summary, -design, -adverse event(s), -meds,-demographics, -lab tests, -mechanistic assays, - files (1)

Intervention Type

drug (7)

diagnostic test (3)

other (3)

behavioral (2)

biological (2)

dietary supplement (1)

genetic (1)

Funder Type

Other (25)

NIH (3)

Industry (2)

Study Type

Observational (15)

Interventional (13)

Observational [Patient Registry] (2)

sle

Showing 26 - 30 of 30

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lupus Erythematosus, Systemic, SLE Trial in Chicago (Physical Therapy or Relaxation Therapy)

Terminated

Lupus Erythematosus, Systemic
SLE

Physical Therapy or Relaxation Therapy

Chicago, Illinois

University of Chicago

Jun 11, 2013

SLE, Lupus Nephritis, Renal Insufficiency Trial (Tacrolimus, cyclophosphamide)

Completed

SLE
+3 more

(no location specified)

Aug 22, 2011

Efferocytosis and Genomic Polymorphism in Autoimmune Diseases

Unknown status

SLE
+2 more

Taipei, Taiwan, Taiwan

Chung-Yi Hu

May 20, 2010

QT Dispersion in Systemic Lupus Erythematosus (SLE)

Completed

Shiraz, Fars, Iran, Islamic Republic of

Shiraz University of Medical Sciences

Dec 12, 2009

Role of DcR3 in T Cell Activation in SLE and RA

Unknown status

SLE
Rheumatoid Arthritis

Taipei, Taiwan

National Taiwan University Hospital

Jan 11, 2006